Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jun 24 | PRAX Praxis Precision Medicines | Stock Option Common Stock | Grant | Acquire A | No | No | 44.25 | 8,566 | 379.05 k | 8,566 |
8 May 24 | TBPH Theravance Biopharma | Ordinary Shares | Grant | Acquire A | No | No | 0 | 10,537 | 0.00 | 80,555 |
8 May 24 | TBPH Theravance Biopharma | Share Option Ordinary Shares | Grant | Acquire A | No | No | 9.49 | 23,576 | 223.74 k | 23,576 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.48 | 25,000 | 87.00 k | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.38 | 20,250 | 169.70 k | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 24.46 | 20,250 | 495.32 k | 0 |
3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.63 | 121,503 | 684.06 k | 0 |
14 Mar 24 | PGEN Precigen | Common Stock | Grant | Acquire A | No | No | 1.43 | 39,510 | 56.50 k | 503,183 |
14 Mar 24 | PGEN Precigen | Option to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 1.43 | 101,626 | 145.33 k | 101,626 |
14 Mar 24 | PGEN Precigen | RSU Common Stock | Grant | Acquire A | No | No | 0 | 87,412 | 0.00 | 87,412 |